SEC Form 4 · accession 0000950142-15-000831
Cidara Therapeutics, Inc. · CDTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steve Elms
Director
Period of report
Apr 20, 2015
Accepted (ET)
Apr 22, 2015 · 7:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610618
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3,F4 | Apr 20, 2015 | C | 351,518 | — | A | 351,518 | I | By Aisling Capital II, L.P. |
| Common StockF1,F4 | holding | — | — | — | 703,092 | I | By Seachaid Pharmaceuticals, LLC. |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Convertible Preferred StockF3,F4,F2 | — | Apr 20, 2015 | C | 8,928,572 | D | — | — | Common Stock | 351,518 | 0 | I |
Explanation of responses
- F1Shares of common stock, par value $0.0001 per share (the "Common Shares") of Cidara Therapeutics, Inc. (the "Issuer") are held directly by Seachaid Pharmaceuticals, LLC. ("Seachaid").
- F2In connection with the Issuer's initial public offering on April 20, 2015, shares of preferred stock, par value $0.0001 per share (the "Preferred Shares") automatically converted into Common Shares on a 25.4-to-1 basis.
- F3Common Shares are directly held by Aisling Capital II, LP ("Aisling").
- F4The investment committee of Aisling holds sole voting and dispositive power over the Common Shares held by Seachaid and Aisling. Aisling is a majority-owner of Seachaid. Aisling Capital Partners LP ("Aisling GP") is the general partner of Aisling and Aisling Capital Partners LLC ("Aisling Partners") is the general partner of Aisling GP. The individual managing members (collectively, the "Managers") of Aisling Partners are Dennis Purcell, Dr. Andrew Schiff and Steve Elms. Aisling GP, Aisling Partners and the Managers share voting and dispositive power over the shares directly held by Aisling and Seachaid. Each of the Reporting Persons disclaims beneficial ownership of the Common Shares, except to the extent of such person's pecuniary interest.